Hsin-Yu Ho

15PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Natural products and bioactive compounds
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 16, 2024
The Role of Ryanodine Receptor 2 Polymorphisms in Oral Squamous Cell Carcinoma Susceptibility and Clinicopathological Features.

Ching-Hui Hsu, San-Fu Hong, Yu-Sheng Lo

|Sep 28, 2024
Association of Titin Polymorphisms with the Progression of Oral Squamous Cell Carcinoma and Its Clinicopathological Characteristics.

Ching-Hui Hsu, Mu-Kuan Chen, Yu-Sheng Lo

|Apr 13, 2024
LDL Receptor-Related Protein 1B Polymorphisms Associated with Increased Risk of Lymph Node Metastasis in Oral Cancer Group with Diabetes Mellitus.

Liang-Cheng Chen, Yu-Sheng Lo, Hsin-Yu Ho

|Jan 23, 2024
The Interaction between CLSPN Gene Polymorphisms and Alcohol Consumption Contributes to Oral Cancer Progression.

Ming-Ju Hsieh, Yu-Sheng Lo, Hsin-Yu Ho

|Sep 09, 2023
Picrasidine J, a Dimeric β-Carboline-Type Alkaloid from Picrasma quassioides, Inhibits Metastasis of Head and Neck Squamous Cell Carcinoma.

Hsin-Yu Ho, Chia-Chieh Lin, Yu-Sheng Lo

Pageof 3